Company Announcements - Jihua Group's main business and existing product system do not involve brain-computer interface related fields [1] - Hongjing Optoelectronics plans to invest 1.533 billion yuan to build a research and manufacturing headquarters project [1] - Zhuojin Co., Ltd. won the bid for soil control project around Longchao Line [1] - Jianghuai Automobile's July sales totaled 25,197 units, a year-on-year decrease of 21.73% [1][2] - Lakala intends to transfer 100% equity of certain subsidiaries [1] - Haitai High-tech completed a buyback, spending a total of 70.91 million yuan to repurchase 6.69995 million shares [1] - Tongchen Beijian reported a net profit of 737 million yuan for the first half of the year, a year-on-year decrease of 17.34% [1][3] - Xuelang Environment's shareholders plan to reduce their holdings by a total of no more than 3% [1] - Huaxia Happiness's shareholders plan to reduce their holdings by a total of no more than 3% [1] - Sanxin Medical plans to issue convertible bonds to raise no more than 530 million yuan [1] - *ST Gaohong's stock may face mandatory delisting due to major legal violations [1] Investment and Financial Data - GAC Group's July automobile sales were 119,482 units, a year-on-year decrease of 15.38% [2] - Minghe Co., Ltd. reported July sales revenue of 41.36 million yuan [2] - Tangrenshen's July pig sales revenue totaled 589.6 million yuan [3] - Tiankang Biological's July pig sales revenue was 335 million yuan [3] - Chongqing Construction's new contract amount for the first half of the year was 24.271 billion yuan, a year-on-year decrease of approximately 19.20% [3] Shareholder Actions - Guangdong Hongda's subsidiary plans to acquire 60% equity of Changzhilin [3] - Ningbo Energy intends to acquire a total of 41% equity of Yongneng Comprehensive Energy [3] - Tianyang Technology plans to invest to acquire 51% equity of Moshuzhiqing [3] - ST Lutong's specific shareholders plan to reduce their holdings by a total of no more than 3.27% [3] - Jiuliang Co., Ltd.'s shareholders plan to reduce their holdings by a total of no more than 3% [3] - Ailis's employee stock ownership platform plans to reduce a total of no more than 13.5 million shares [3] - Huaxia Happiness's shareholders plan to reduce their holdings by a total of no more than 3% [3] Other Developments - Sanxin Medical plans to use the raised funds for the expansion project of producing 10 million blood dialysis membranes and 10 million blood dialysis devices [3]

（文章来源：证券日报） 证券日报网讯 8月8日晚间，三鑫医疗发布公告称，公司第五届董事会第二十一次会议审议通过了《关 于及其摘要的议案》等多项议案。 ...

证券日报网讯 8月8日晚间，三鑫医疗发布公告称，公司第五届监事会第十九次会议审议通过了《关于 公司及其摘要的议案》等多项议案。 （文章来源：证券日报） ...

证券日报网讯8月8日晚间，三鑫医疗（300453）发布公告称，公司将于2025年8月26日召开2025年第一 次临时股东大会。本次股东大会将审议《关于2025年中期利润分配预案的议案》等多项议案。 ...

Mergers and Acquisitions - Guangdong Hongda's subsidiary, Hongda Defense, plans to acquire 60% equity of Changzhilin for 1.02 billion yuan to strengthen its defense equipment sector. After the transaction, Hongda Defense will become the controlling shareholder of Changzhilin. This transaction does not constitute a related party transaction or a major asset restructuring and does not require shareholder approval [1] - Ningbo Energy intends to acquire 100% equity of Yongneng Comprehensive Energy by purchasing 41% equity held by Ningbo Meike and Ningbo Guotong for a total of approximately 7.84 million yuan, including transitional profit and loss sharing [2] - Tianyang Technology plans to invest 30.6 million yuan to acquire 51% equity of Moshuzhiqing, making it a subsidiary and included in the consolidated financial statements. Moshuzhiqing is recognized as a leading AI company in China [3] Performance Disclosure - Sanxin Medical reported a 10.83% year-on-year increase in revenue to 761 million yuan and a net profit attributable to shareholders of 115 million yuan, up 8.35% year-on-year for the first half of 2025 [4] - Huili B's revenue decreased by 0.11% to 7.635 million yuan, but net profit surged by 1222.72% to 42.1042 million yuan, primarily due to a transfer of equity in Huili Coating Company [5] - Jinlongyu's revenue increased by 32.98% to 2.157 billion yuan, but net profit decreased by 20.19% to 66.716 million yuan, attributed to the current instability in solid-state battery and key materials business [6] Shareholding Changes - Xiongdi Technology's major shareholder and director Gao Jing plans to reduce his stake by up to 3%, equivalent to 559,900 shares, within three months after the announcement [7] - Xuelang Environment's shareholders Yang Jianping and Xu Huifen plan to reduce their holdings by up to 3%, totaling 999,430 shares, for family asset planning purposes [8] - Ailis's employee stock ownership platform plans to reduce its stake by up to 3%, totaling 13.5 million shares, within three months starting from September 1, 2025 [9] Regulatory Issues - *ST Gaohong received a notice from the China Securities Regulatory Commission regarding potential major illegal delisting due to suspected information disclosure violations, including fraudulent issuance of shares and false records in annual reports from 2015 to 2023 [10] - Jihua Group has been placed under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [11] - Haoli Technology's actual controller was penalized by the China Securities Regulatory Commission for information disclosure violations, resulting in a fine of 4 million yuan [12]

Mergers and Acquisitions - Guangdong Hongda's subsidiary, Hongda Defense, plans to acquire 60% of Changzhilin for 1.02 billion yuan to strengthen its defense equipment segment, making Hongda Defense the controlling shareholder post-transaction [1] - Ningbo Energy intends to acquire 100% of Yongneng Comprehensive Energy by purchasing 41% stakes from Ningbo Meike and Ningbo Guotong for a total of 913.87 thousand yuan [2] - Tianyang Technology plans to invest 30.6 million yuan to acquire 51% of Moshuzhiqing, which will become a subsidiary and included in the consolidated financial statements [3] Performance Disclosure - Sanxin Medical reported a 10.83% year-on-year increase in revenue to 761 million yuan and an 8.35% increase in net profit attributable to shareholders to 115 million yuan for the first half of 2025 [4] - Huili B's revenue decreased by 0.11% to 7.635 million yuan, but net profit surged by 1222.72% to 42.1042 million yuan, primarily due to a transfer of equity resulting in an investment gain of 51.9596 million yuan [5] - Jinlongyu's revenue increased by 32.98% to 2.157 billion yuan, but net profit decreased by 20.19% to 66.716 million yuan, with solid-state battery business not yet contributing significantly to overall performance [6] Shareholding Changes - Xiongdi Technology's director Gao Jing plans to reduce his stake by up to 3%, equating to 559.9 thousand shares, within three months after the announcement [7] - Xuelang Environment's shareholders Yang Jianping and Xu Huifen plan to reduce their holdings by up to 3%, totaling 999.43 thousand shares, for family asset planning reasons [8] - Ailis's employee stock ownership platform plans to reduce its stake by up to 3%, totaling 1.35 million shares, within three months starting from September 1, 2025 [9]

按申万行业统计，三鑫医疗所属的医药生物行业共有6家公司公布了2025半年度分配方案，派现金额最 多的是药明康德，派现金额为10.03亿元，其次是硕世生物、九洲药业，派现金额分别为2.85亿元、1.76 亿元。（数据宝） 2025半年度医药生物行业分红排名 | 代码 | 简称 | 每10股送转 | 每10股派现 | 派现金额（万 | 派现占净利润比例 | 股息率 | | --- | --- | --- | --- | --- | --- | --- | | | | （股） | （元） | 元） | （%） | （%） | | 603259 | 药明康 德 | 0.00 | 3.5 | 100308.38 | 11.72 | 0.58 | | 688399 | 硕世生 物 | 0.00 | 34 | 28516.39 | 7142.28 | 5.17 | | 603456 | 九洲药 业 | 0.00 | 2 | 17634.20 | 33.54 | 1.42 | | 000915 | 华特达 因 | 0.00 | 5 | 11716.57 | 34.72 | 1.72 | | 002107 | 沃华医 药 | ...

（文章来源：每日经济新闻） 三鑫医疗（SZ 300453，收盘价：9.05元）8月8日晚间发布公告称，江西三鑫医疗科技股份有限公司控 股子公司宁波菲拉尔医疗用品有限公司于近日获得了国家药品监督管理局颁发的《医疗器械注册证》。 产品名称为"一次性使用左心吸引头"。 2025年1至6月份，三鑫医疗的营业收入构成为：医疗器械行业占比99.78%，其他业务占比0.22%。 ...

Core Viewpoint - Sanxin Medical (300453.SZ) announced a plan to issue convertible bonds to unspecified objects, aiming to raise a total of no more than 530 million yuan, which will be used for various projects including the expansion of blood dialysis membrane and blood dialysis device production [1] Group 1 - The total amount to be raised from the bond issuance is capped at 530 million yuan, including the principal [1] - The net proceeds after deducting issuance costs will be fully allocated to several projects, including the annual production expansion of 10 million blood dialysis membranes and devices [1] - Additional projects include the establishment of a new production line for 30 million sets of blood dialysis tubing and the expansion of the Jiangxi Chengtukang electronic accelerator irradiation sterilization production line [1]

每经AI快讯，三鑫医疗（SZ 300453，收盘价：9.05元）8月8日晚间发布公告称，公司第五届第二十一 次董事会会议于2025年8月7日在公司会议室召开。会议审议了《关于修订/新增公司制度的议案》等文 件。 截至发稿，三鑫医疗市值为47亿元。 每经头条（nbdtoutiao）——调查：这类高频交易，一年佣金可达两个亿！监管明确禁止向投资者返佣 金，但禁令下暗藏博弈 （记者 曾健辉） 2025年1至6月份，三鑫医疗的营业收入构成为：医疗器械行业占比99.78%，其他业务占比0.22%。 ...